Argenx Q3 Profit Rises to $506 Million
Argenx reported third-quarter profit attributable to owners of $506 million, up from $344 million a year earlier.
WASHINGTON (dpa-AFX) — Immunology company argenx SE (ARGX) said Thursday that third-quarter net income was higher than a year earlier. Profit attributable to the parent’s owners rose to 506 million from 344 million in the prior-year period.